Baculovirus Expression System Market, By Product Type (Baculovirus, Expression Vector, Reagents, and Others), By Application (Therapeutics, Vaccines, Protein Purification, and Others), By End User (Biopharmaceutical Companies, Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Dec 2023

Code : CMI6360

Pages :140

Formats :

Excel and PDF

Industry : Biotechnology

Market News

Recent Developments:

New product launches:

In February 2023, Thermo Fisher Scientific, a U.S.-based supplier and analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services company, announced launch of the BaculoDirect Baculovirus Expression System, which is a streamlined system for the production of recombinant proteins in insect cells. The system includes a new vector, transferrin receptor-mediated transfection (TRMT) technology, and a new Sf9 insect cell line.
In March 2023, Oxford Expression Technologies, a K.-based biotechnology company, launched the AcMNPV BaculoDirect Expression System, which is a system for the rapid and efficient production of recombinant proteins in insect cells. The system includes a new vector, a new insect cell line, and a transfection reagent.
In April 2023, Promega Corporation, a U.S.-based manufacturer of enzymes and other products for biotechnology and molecular biology company, launched the pFastBac Dual Baculovirus Expression System, which is a system for the production of two recombinant proteins in insect cells from a single vector. The system includes a new vector, a new insect cell line, and a transfection reagent.

Acquisitions and partnerships:

In April 2022, Thermo Fisher Scientific, a U.S.-based supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services, partnered with Watchmaker Genomics, is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA. To improve AAV production for gene therapy using the Thermo Fisher Baculovirus Expression Vector System.
In June 2021, Aragen Bioscience, a global leader in providing drug discovery, drug development, and manufacturing solutions for life sciences, acquired Exelead's CMO business to expand its biologics and viral vector CDMO capabilities including Baculovirus-insect cell expression platforms.
In May 2020, Sartorius AG, a global laboratory and process technology provider for the biotech, pharmaceutical, and food industries, acquired a majority stake in cell culture media expert biological industries. This enhanced Sartorius AG's expertise in insect cell culture media for baculovirus expression.